Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Brotchie

Showing results (51-60 of 127) with videos related to

Pageof 13
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 15, 2006
Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of Parkinson's diseaseJordi Gomez-Ramirez, Tom H Johnston, Naomi P Visanji, et al.
Human Molecular Genetics|October 19, 2012
Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient miceMin Lang, Robert G Wither, Jonathan M Brotchie, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2003
Sonic hedgehog is a neuromodulator in the adult subthalamic nucleusErwan Bezard, Jerome Baufreton, Geraint Owens, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 24, 2012
L-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's diseasePhilippe Huot, Tom H Johnston, James B Koprich, et al.
Neurobiology of Aging|November 6, 2010
Regulation of cortical and striatal 5-HT1A receptors in the MPTP-lesioned macaquePhilippe Huot, Tom H Johnston, James B Koprich, et al.
Plos One|March 17, 2011
Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synucleinJames B Koprich, Tom H Johnston, Philippe Huot, et al.
Neurobiology of Disease|January 3, 2009
Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's diseaseNaomi P Visanji, Susan H Fox, Tom Johnston, et al.
Scientific Reports|June 12, 2019
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson's DiseaseJay S Schneider, Radha Aras, Courtney K Williams, et al.
Human Molecular Genetics|January 29, 2008
Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient miceDenis G M Jugloff, Katrina Vandamme, Richard Logan, et al.
Neuropharmacology|July 16, 2008
Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in ratsSebastien Lopez, Nathalie Turle-Lorenzo, Tom H Johnston, et al.
Pageof 13

Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
Movement Disorders : Official Journal of the Movement Disorder Society|March 15, 2006
Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of Parkinson's diseaseJordi Gomez-Ramirez, Tom H Johnston, Naomi P Visanji, et al.
Human Molecular Genetics|October 19, 2012
Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient miceMin Lang, Robert G Wither, Jonathan M Brotchie, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2003
Sonic hedgehog is a neuromodulator in the adult subthalamic nucleusErwan Bezard, Jerome Baufreton, Geraint Owens, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 24, 2012
L-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's diseasePhilippe Huot, Tom H Johnston, James B Koprich, et al.
Neurobiology of Aging|November 6, 2010
Regulation of cortical and striatal 5-HT1A receptors in the MPTP-lesioned macaquePhilippe Huot, Tom H Johnston, James B Koprich, et al.
Plos One|March 17, 2011
Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synucleinJames B Koprich, Tom H Johnston, Philippe Huot, et al.
Neurobiology of Disease|January 3, 2009
Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's diseaseNaomi P Visanji, Susan H Fox, Tom Johnston, et al.
Scientific Reports|June 12, 2019
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson's DiseaseJay S Schneider, Radha Aras, Courtney K Williams, et al.
Human Molecular Genetics|January 29, 2008
Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient miceDenis G M Jugloff, Katrina Vandamme, Richard Logan, et al.
Neuropharmacology|July 16, 2008
Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in ratsSebastien Lopez, Nathalie Turle-Lorenzo, Tom H Johnston, et al.
Pageof 13